At GI Cancer Trials (formerly AGITG and GI Cancer Institute), we are committed to building a better future for people with gastro-intestinal (GI) cancer. Our diverse network of clinicians, researchers, and community advocates, work together to deliver clinical trials that lead to better treatments, improved quality of life, and longer survival.
Since 1991, we’ve conducted 92 research studies, giving more than 10,100 people access to promising new treatments, faster. The scope of these trials extends not only across 135 sites in Australia and Aotearoa New Zealand, but to 169 sites across Asia, Europe, North America and the Middle East.
Our vision
A better future for people with GI cancer.
Our purpose
We bring together a diverse network of brilliant people to deliver clinical trials that improve outcomes for people affected by GI cancers.
Numbers are collective numbers since 1991 and accurate as at 31 December 2025. Research studies includes start-up, open, in follow-up and completed clinical trials, endorsed clinical trials, and translational research studies.
Our research
Clinical trials are how progress happens. They test whether new treatments work better than the current standard of care, and they’re essential to ensuring new therapies are safe, effective, and ready to be used more widely.
For patients, clinical trials can offer immediate access to the latest treatments and often improve both outcomes and quality of life. Running trials here in Australia means people can benefit from these advances up to five years earlier than if the trials were held overseas.
Our research has made a lasting impact on how GI cancers are treated, both in Australia and around the world.
Read about our research impact
Our membership
With more than 2,000 members across Australia and Aotearoa New Zealand, our multidisciplinary network connects clinicians, researchers, nurses, allied health professionals and trial coordinators who are all working to transform outcomes for people with GI cancer.
Together, these members not only bring diverse experience and skills, but the collective technical and logistical capability necessary to perform cancer trials. Our leaders promote a culture of idea generation, passion and goodwill, with extensive opportunities for involvement including Committee positions, trial development pathways, Preceptorships and the Annual Scientific Meeting.
In 2008, recognising the need for greater involvement from GI cancer patients, survivors, carers and family members, we established the Community Advisory Panel (CAP) as part of the membership. Most importantly, the CAP provides advice on general research directions and priorities from the perspective of their lived experience with GI cancer.
Raising funds for new GI cancer trials
We raise awareness of GI cancer trials and fundraise to support new research. We share patient and survivor stories to help support patients and their families through their GI cancer journey.
Our dedicated GI cancer community supports us in a number of ways: through regular appeals, community fundraising events, the Gutsy Challenge, bequests, and in memory giving. We continue to grow our regular giving supporter base, which provides us with financial stability to plan for the future.